Business Practice

Researchers find significant variation in regulation of pharmaceutical market systems in the developing world

How harmonization and international standards bodies bind trade and regulation in the pharma industry

In certain areas, there is significant disharmony across the ICH regions…

Margaret Hamburg, former FDA Commissioner, has led the agency through a period of increasing globalization.

Globalization has created an industrywide demand for regulatory harmonization. But who benefits?

Sitting Down With... Cornell Stamoran, Vice President of Corporate Strategy, Catalent Pharma Solutions, USA.

Is age related to research productivity – and, if so, to what extent?

Record generic approvals, a joint opioid investigation... What’s new for pharma in business?

An exhibition in London explores the relationship between graphic design and health.

The future status of pharma intellectual property in the UK depends on the outcome of Brexit.